Patents by Inventor Cheryl M. Gentile

Cheryl M. Gentile has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal administration of azapirones
    Patent number: 5837280
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 17, 1998
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile
  • Transdermal administration of azapirones
    Patent number: 5817331
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 6, 1998
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile
  • Transdermal administration of azapirones
    Patent number: 5633009
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: May 27, 1997
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile
  • Breathable backing
    Patent number: 4994278
    Abstract: A composition comprising a flexible backing for a transdermal drug preparation with a water vapor transmission rate about equal to or in excess of that of ethylene vinyl alcohol copolymer, namely equal to or in excess of, at one mil thickness, of about 2 to 4 grams and more preferably in excess of 6 grams per 24 hours per 100 square inches at 40.degree. C. and 90% relative humidity and an oxygen transmission rate equal to or less than ethylene vinyl alcohol copolymer, namely at one mil thickness equal to or less than about 0.01 to 0.1 cubic centimeters per 100 square inches measured over 24 hours at 1 atmospheric pressure, 20.degree. C. and 65% relative humidity.
    Type: Grant
    Filed: January 11, 1989
    Date of Patent: February 19, 1991
    Assignee: Noven Pharmaceuticals, Inc.
    Inventors: Steven Sablotsky, Cheryl M. Gentile